Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA PANACEA BIOTECH DISHMAN PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 30.0 -60.9 - View Chart
P/BV x 3.3 0.9 380.1% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
PANACEA BIOTECH
Mar-23
DISHMAN PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs374191 195.7%   
Low Rs129107 120.3%   
Sales per share (Unadj.) Rs197.075.1 262.3%  
Earnings per share (Unadj.) Rs21.2-5.5 -384.6%  
Cash flow per share (Unadj.) Rs34.70.9 3,952.4%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.9137.7 130.6%  
Shares outstanding (eoy) m80.7061.25 131.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.0 64.3%   
Avg P/E ratio x11.9-27.1 -43.8%  
P/CF ratio (eoy) x7.3170.0 4.3%  
Price / Book Value ratio x1.41.1 129.1%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3079,142 222.1%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3551,265 423.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,8984,599 345.6%  
Other income Rs m265517 51.4%   
Total revenues Rs m16,1635,116 315.9%   
Gross profit Rs m4,10347 8,726.5%  
Depreciation Rs m1,091391 278.8%   
Interest Rs m94444 2,128.5%   
Profit before tax Rs m2,334128 1,822.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624466 134.0%   
Profit after tax Rs m1,710-337 -506.7%  
Gross profit margin %25.81.0 2,524.7%  
Effective tax rate %26.7363.5 7.4%   
Net profit margin %10.8-7.3 -146.6%  
BALANCE SHEET DATA
Current assets Rs m11,0185,623 195.9%   
Current liabilities Rs m9,5173,297 288.6%   
Net working cap to sales %9.450.6 18.7%  
Current ratio x1.21.7 67.9%  
Inventory Days Days5759 97.1%  
Debtors Days Days348 7.3%  
Net fixed assets Rs m18,7877,028 267.3%   
Share capital Rs m16161 263.5%   
"Free" reserves Rs m14,3548,375 171.4%   
Net worth Rs m14,5168,436 172.1%   
Long term debt Rs m4,189202 2,077.7%   
Total assets Rs m29,80512,712 234.5%  
Interest coverage x3.53.9 89.3%   
Debt to equity ratio x0.30 1,207.5%  
Sales to assets ratio x0.50.4 147.4%   
Return on assets %8.9-2.3 -386.3%  
Return on equity %11.8-4.0 -294.5%  
Return on capital %17.52.0 877.9%  
Exports to sales %24.943.3 57.5%   
Imports to sales %3.724.4 15.3%   
Exports (fob) Rs m3,9561,992 198.6%   
Imports (cif) Rs m5941,124 52.9%   
Fx inflow Rs m4,9521,992 248.5%   
Fx outflow Rs m6971,191 58.5%   
Net fx Rs m4,255801 530.9%   
CASH FLOW
From Operations Rs m2,786-4,225 -66.0%  
From Investments Rs m-1,5294,303 -35.5%  
From Financial Activity Rs m-941-184 512.2%  
Net Cashflow Rs m317-105 -301.5%  

Share Holding

Indian Promoters % 61.4 73.6 83.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 1.0 2,415.8%  
FIIs % 12.0 0.3 4,603.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 26.4 146.2%  
Shareholders   52,291 47,091 111.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Panacea Biotech Share Price Performance

Period Dishman Pharma Panacea Biotech S&P BSE HEALTHCARE
1-Day 2.87% -1.74% 1.18%
1-Month -2.45% -20.01% -0.75%
1-Year 96.38% 11.75% 61.82%
3-Year CAGR 89.34% -12.26% 18.16%
5-Year CAGR 38.20% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.